» Articles » PMID: 26565557

Multiple-Objective Optimal Designs for Studying the Dose Response Function and Interesting Dose Levels

Overview
Journal Int J Biostat
Specialty Public Health
Date 2015 Nov 14
PMID 26565557
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We construct an optimal design to simultaneously estimate three common interesting features in a dose-finding trial with possibly different emphasis on each feature. These features are (1) the shape of the dose-response curve, (2) the median effective dose and (3) the minimum effective dose level. A main difficulty of this task is that an optimal design for a single objective may not perform well for other objectives. There are optimal designs for dual objectives in the literature but we were unable to find optimal designs for 3 or more objectives to date with a concrete application. A reason for this is that the approach for finding a dual-objective optimal design does not work well for a 3 or more multiple-objective design problem. We propose a method for finding multiple-objective optimal designs that estimate the three features with user-specified higher efficiencies for the more important objectives. We use the flexible 4-parameter logistic model to illustrate the methodology but our approach is applicable to find multiple-objective optimal designs for other types of objectives and models. We also investigate robustness properties of multiple-objective optimal designs to mis-specification in the nominal parameter values and to a variation in the optimality criterion. We also provide computer code for generating tailor made multiple-objective optimal designs.

Citing Articles

A model-based approach to designing developmental toxicology experiments using sea urchin embryos.

Collins M, Cui E, Hyun S, Wong W Arch Toxicol. 2022; 96(3):919-932.

PMID: 35022802 PMC: 8850257. DOI: 10.1007/s00204-021-03201-1.


Optimal designs based on the maximum quasi-likelihood estimator.

Shen G, Hyun S, Wong W J Stat Plan Inference. 2017; 178:128-139.

PMID: 28163359 PMC: 5287418. DOI: 10.1016/j.jspi.2016.07.002.

References
1.
Sebaugh J . Guidelines for accurate EC50/IC50 estimation. Pharm Stat. 2012; 10(2):128-34. DOI: 10.1002/pst.426. View

2.
McGree J, Eccleston J, Duffull S . Compound optimal design criteria for nonlinear models. J Biopharm Stat. 2008; 18(4):646-61. DOI: 10.1080/10543400802071352. View

3.
Huang Y, Wong W . Sequential construction of multiple-objective optimal designs. Biometrics. 1999; 54(4):1388-97. View

4.
Sverdlov O, Ryeznik Y, Wong W . Efficient and ethical response-adaptive randomization designs for multi-arm clinical trials with Weibull time-to-event outcomes. J Biopharm Stat. 2014; 24(4):732-54. DOI: 10.1080/10543406.2014.903261. View

5.
Miller F, Guilbaud O, Dette H . Optimal designs for estimating the interesting part of a dose-effect curve. J Biopharm Stat. 2007; 17(6):1097-115. DOI: 10.1080/10543400701645140. View